肺癌沉默基因解决方案.ppt

Background Because of increased resistance to apoptosis in tumor cells, inhibition of specific antiapoptotic factors may provide a rational approach for the development of novel therapeutic strategies.Livin, a novel inhibitor of apoptosis protein family, has been found to be expressed in various malignancies and is suggested to have poorly prognostic significance. However, no data are available concerning the significance of livin in gastric cancer. In this study, we detected the expression of livin in human gastric carcinoma and investigated the apoptotic susceptibility of SGC-7901 cell by shRNAmediated silencing of the livin gene. 背景 由于肿瘤细胞抑制凋亡增殖,特定凋亡的抑制因素会对于发展新的治疗策略提供一个合理途径。Livin是一种凋亡抑制蛋白家族成员，在多种恶性肿瘤的表达中具有意义。但是, 在有关胃癌方面没有可利用的数据。在本研究中,我们发现livin基因在人类胃癌中的表达并调查了介导的shRNA能抑制肺癌细胞中livin沉默基因的表达，从而促进SGC-7901细胞凋亡。 1. Introduction Gastric cancer is one of the most common malignancies in the world. Most patients with this disease are diagnosed in advanced stages, and lose the chance of surgical eradication. Despite much progress in chemotherapy, the overall survival of the patients with gastric cancer in advanced stage is still poor. Resistance of cancer cells to chemoagents may contribute to failure of the treatment. Among the reasons of drug resistance, inhibited process of cell apoptosis may play an important role. 1．介绍 胃癌是世界上最常见的恶性肿瘤之一。大多数患者被诊断为这个疾病的阶段,在最佳时间的机会错失了手术治愈。尽管有很大改善,但处于晚期胃癌的化疗患者的总体存活率仍然很低。癌症细胞化疗耐抗性可能导致手术失败。在耐药的原因中,抑制细胞凋亡的过程会起重要作用。癌细胞常有抗凋亡增长的特征[1],介导其增加的阻力不同来刺激的细胞凋亡,如DNA损伤、缺氧、营养损失[2、3]。此外, 在临床实践中细胞凋亡抵抗被认为是肿瘤手术失败的主要原因,因此许多化疗药物和/或放射线疗法都是通过诱导凋亡肿瘤死亡实现的[4] In the present study, we investigated the expression of livin in gastric cancinomas and their adjacent tissues. The relationship between livin expression and clinical pathologic parameters was analyzed. Furthermore, we explored the feasibility of shRNA in inhibiting livin gene expression and the apoptotic susceptibility of gastric cancer cell by shRNA-mediated silencing of the livin gene. 在目前的研究中,我们调查了livin的表